Heat Biologics, Inc.
HTBXAMEXHealthcare
$2.38
+$0.01(+0.42%)
Market Cap$61074370
P/E Ratio—
52W High$2.48
52W Low$2.33
Heat Biologics, Inc.（HTBX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · HTBX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.11M | $2.95M | $3.05M | $5.79M | $1.52M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $2.11M | $2.95M | $3.05M | $5.79M | $1.52M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $18.82M | $12.94M | $13.01M | $16.23M | $8.27M |
| G&A Expenses | $16.83M | $15.00M | $9.43M | $7.03M | $0.00M |
| Total Operating Expenses | $37.53M | $27.94M | $22.44M | $23.26M | $14.64M |
| Operating Income | ($35.42M) | ($26.12M) | ($20.75M) | ($17.96M) | ($13.34M) |
| Operating Margin %(computed) | — | -886.18% | -680.39% | -309.99% | -877.85% |
| Interest Income | $0.82M | $0.57M | $0.43M | $0.27M | $0.02M |
| Interest Expense | $0.13M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($35.55M) | ($26.38M) | ($20.34M) | ($17.58M) | ($13.22M) |
| Income Tax Expense | ($0.15M) | ($0.26M) | $0.05M | ($0.99M) | ($0.81M) |
| Net Income | ($35.40M) | ($26.05M) | ($20.02M) | ($15.73M) | ($11.84M) |
| Net Margin %(computed) | — | -883.65% | -656.51% | -271.56% | -779.09% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.41 | $-1.63 | $-4.21 | $-6.30 | $-21.56 |
| Wtd Avg Shares | 25.14M | 15.98M | 4.75M | 2.50M | 0.55M |
| EBITDA | ($35.55M) | ($25.72M) | ($19.74M) | ($16.48M) | ($12.52M) |
| EBITDA Margin %(computed) | — | -872.35% | -647.40% | -284.47% | -823.53% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Heat Biologics, Inc.
关于Heat Biologics, Inc.（HTBX）损益表
Heat Biologics, Inc.（HTBX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2021财年，HTBX实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.04B)（净利率-1675.54%）。
常见问题
HTBX · 4 问Heat Biologics, Inc.（HTBX）2021财年营收为$0.00B，同比down28.3%。
HTBX revenueHTBX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09